Trehalose

N/A

Report date: 2023/04/04 20:00:35
NME

Base Information

Drug NameTrehalose
Drug Alias Name海藻糖Trehalose dihydrate海藻醣CabalettaSLS-005
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionAutophagy stimulants
TargetsNot applicable
Therapy Area/IndicationsBipolar DisorderDiabetes Mellitus, Type 2Acute Coronary Syndrome +[8
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPortugal +[12
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesBioblast Pharma
China Registration ClassN/A

Develop Information

Active IndicationsBipolar DisorderDiabetes Mellitus, Type 2Amyotrophic Lateral Sclerosis
Inactive IndicationsAcute Coronary SyndromeAlzheimer DiseaseMachado-Joseph Disease +[5

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG